DSFIR Share Price Performance
€0
-99.00 (-100.00%)
Price €0
Fair Value€98.68
Share Pricen/a
Narrative Update • Jun 08
DSM-Firmenich AG Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 59 Fair Values set on narratives written by author
DSFIR Community Narratives
AN
Fair Value
·Fair Value €98.68 27.5% undervalued intrinsic discount
Sustainability And Precision Nutrition Will Fuel Global Market Expansion
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value
·Fair Value €79.82 10.4% undervalued intrinsic discount
DSFIR: Resilient Consumer Health Demand Will Drive Performance Amid Pricing Pressure
0users have liked this narrative
0users have commented on this narrative
28users have followed this narrative
AN
Fair Value
·Fair Value €60.56 18.1% overvalued intrinsic discount
Regulatory And Merger Challenges Will Constrain Benefits But Spark Growth
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Sustainability And Precision Nutrition Will Fuel Global Market Expansion
DSM-Firmenich is reshaping itself after a major merger and planned sell-offs, aiming to focus on cleaner, bio-based ingredients that big food, health, and beauty brands increasingly want. The upside comes from faster cost savings and a stronger pipeline of new products—but the merger integration, tougher rules, and fierce competition could still drag on results.Read more
AN
€98.68
27.5% undervalued intrinsic discount
Fair Value
Revenue
5.97% p.a.
Profit Margin
11.99%
Future PE
19.94x
Price in 2029
€117.49
Regulatory And Merger Challenges Will Constrain Benefits But Spark Growth
DSM-Firmenich is riding rising demand for healthier, more sustainable ingredients, but tougher rules and more complex supply chains could eat into the benefits. The merger could unlock improvements, yet messy integration, currency swings, and fast-moving new technologies may hold back growth and profits.Read more
AN
€60.56
18.1% overvalued intrinsic discount
Fair Value
Revenue
2.44% p.a.
Profit Margin
5.27%
Future PE
30.82x
Price in 2029
€72.13
DSFIR: Resilient Consumer Health Demand Will Drive Performance Amid Pricing Pressure
Key Takeaways Focus on health-driven innovations, sustainability, and bio-based solutions enhances product differentiation, pricing power, and positions DSM-Firmenich for sustained organic growth. Integration synergies and increased exposure to local and regional customers boost margin improvements and revenue stability amid tightening sustainability regulations.Read more
AN
€79.82
10.4% undervalued intrinsic discount
Fair Value
Revenue
3.56% p.a.
Profit Margin
7.51%
Future PE
27.68x
Price in 2029
€95.34
Trending Discussion
Recently Updated Narratives
AN
DSFIR: Share Buyback And Dual Listing Will Support Re Rating
Fair Value: €98.68 27.5% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
DSFIR: Reset Profitability Expectations Will Pressure Future Margin Resilience
Fair Value: €60.56 18.1% overvalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
DSFIR: Share Buyback And Execution Discipline Will Support Future Re Rating
Fair Value: €79.82 10.4% undervalued intrinsic discount
28 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
DSM-Firmenich AG Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Jul 30, 2026
- 1.10
- 39.07%
- 3.03%
- 26.1%
About DSFIR
- Founded
- 1902
- Employees
- 26873
- CEO
- WebsiteView website
DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through Perfumery & Beauty; Taste, Texture & Health; and Health, Nutrition & Care segments. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and sugar reduction; and food enzymes, hydrocolloids, cultures, natural colorants, nutritional ingredients, and plant-based proteins. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, biomedical materials, and nutrition improvement markets. This segment also offers vitamins, nutritional lipids, minerals, carotenoids, botanical nutraceuticals, digestive enzymes, postbiotics, probiotics and prebiotics, and active pharmaceutical ingredients; biomedical solutions; and premix, market-ready, and personalized nutrition solutions, as well as expert services in regulatory affairs and nutrition. DSM-Firmenich AG was founded in 1902 and is based in Kaiseraugst, Switzerland.
